{"id":"NCT02517021","sponsor":"Helsinn Healthcare SA","briefTitle":"A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting","officialTitle":"A Phase 3, Multicenter, Randomized, Double-blind, Active Control Study to Evaluate the Safety and Efficacy of IV Pro-netupitant/Palonosetron (260 mg/0.25 mg) Combination for the Prevention of Chemotherapy-induced Nausea and Vomiting in Repeated Chemotherapy Cycles in Patients Receiving Highly Emetogenic Chemotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-11","primaryCompletion":"2016-08","completion":"2016-08","firstPosted":"2015-08-06","resultsPosted":"2018-06-20","lastUpdate":"2018-06-20"},"enrollment":405,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Chemotherapy-Induced Nausea and Vomiting"],"interventions":[{"type":"DRUG","name":"Pro-netupitant/Palonosetron","otherNames":["IV NEPA FDC"]},{"type":"DRUG","name":"Netupitant/Palonosetron","otherNames":["Oral NEPA FDC"]},{"type":"DRUG","name":"Dexamethasone","otherNames":[]}],"arms":[{"label":"Pro-netupitant/Palonosetron plus Dexamethasone","type":"EXPERIMENTAL"},{"label":"Netupitant/Palonosetron plus Dexamethasone","type":"ACTIVE_COMPARATOR"}],"summary":"NEPA-15-18 is a clinical study assessing safety of pro-netupitant and palonosetron, two antiemetic drugs, given with oral dexamethasone. The objective of the study is to evaluate if pro-netupitant and palonosetron are safe when administered to prevent nausea and vomiting after administration of repeated cycles of chemotherapy.","primaryOutcome":{"measure":"Percentage of Patients With Adverse Events","timeFrame":"Participants will be followed for the duration of the chemotherapy, an expected average duration of up to 14 weeks assuming a maximum of 4 chemotherapy cycles given every 3 weeks.","effectByArm":[{"arm":"Pro-netupitant/Palonosetron Plus Dexamethasone","deltaMin":169,"sd":null},{"arm":"Netupitant/Palonosetron Plus Dexamethasone","deltaMin":174,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":23},"locations":{"siteCount":74,"countries":["United States","Austria","Croatia","Czechia","Germany","Israel","Italy","Poland","Serbia","South Africa","Spain","Ukraine"]},"refs":{"pmids":["29722791"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":41,"n":203},"commonTop":["Neutropenia","Anaemia","Alopecia","Constipation","Leukopenia"]}}